Varex Imaging Corporation (VREX) declined 13.28%, closing at $10.28, down $1.57, after reporting its fourth quarter and full-year 2025 financial results.
Fourth-quarter revenue rose 11 percent year-over-year to $229 million, driven by strong growth in its Industrial segment, up 25 percent, and solid advances in its CT tube business. For the full year, revenue reached $845 million, up about 4 percent.
Despite the revenue strength, Varex reported a net loss of $1.70 per share for FY25 and offered cautious guidance for FY26, expecting first-quarter revenues of $200 million to $215 million and adjusted EPS of $0.05 to $0.25, reflecting underlying pressure in its medical components business.
On the day of the announcement, VREX experienced an unusually heavy trading volume as investors weighed mixed results and conservative forward guidance. The stock's 52-week range is approximately $9.40 - $20.80.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.